Zhejiang Zhenyuan

Zhejiang Zhenyuan is a prominent healthcare conglomerate headquartered in Shaoxing, China, that integrates pharmaceutical R&D, manufacturing, distribution, and retail. The company operates through its core subsidiary, Zhejiang Zhenyuan Pharmaceutical, which is a major producer of macrolide antibiotics and biochemical drugs, including Adenosylmethionine and various API products. Beyond manufacturing, Zhejiang Zhenyuan maintains an extensive pharmaceutical wholesale network and a large chain of retail pharmacies across the Zhejiang region. Publicly traded on the Shenzhen Stock Exchange since 1997, the company serves as a key player in the Chinese domestic drug supply chain. Its manufacturing facilities are GMP-certified and capable of large-scale fermentation and chemical synthesis.